A team of researchers from the University of Utah and Sethera Therapeutics has uncovered a powerful new way to build more stable and drug-like peptides, opening the door to medicines that could target diseases long considered “undruggable.” Their findings are published last week in the Proceedings of the National Academy of Sciences.
Natural enzyme expands possibilities for peptide drug discovery
